Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Yomeishu Seizo Co., Ltd. (2540:JPX), powered by AI.
Yomeishu Seizo Co., Ltd. is currently trading at ¥4,030. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Yomeishu Seizo Co., Ltd. on Alpha Lenz.
Yomeishu Seizo Co., Ltd.'s P/E ratio is 82.1.
“Yomeishu Seizo Co., Ltd. trades at a P/E of 82.1 (premium valuation) with modest ROE of 1.5%.”
Ask for details →Yomeishu Seizo Co., Ltd. is a renowned Japanese company specializing in the production and distribution of health beverages. Its primary product, Yomeishu, is a herbal medicinal liquor known for promoting wellness and aiding digestion. The company has established itself as a leader in the health beverage industry, with a strong heritage of combining traditional Japanese herbal knowledge with modern production techniques. Yomeishu Seizo Co. caters primarily to health-conscious consumers seeking natural remedies as part of their dietary regimen. The company operates primarily within Japan, but its products have also gained international interest, reflecting the growing global trend towards holistic health solutions. In the financial market, Yomeishu Seizo Co. plays a vital role amongst health-focused consumer goods companies, offering investors exposure to the alternative medicine sector. The company's long-standing tradition and dedicated consumer base underscore its significance in promoting healthy lifestyles through culturally-influenced, naturally-derived products.
“Yomeishu Seizo Co., Ltd. trades at a P/E of 82.1 (premium valuation) with modest ROE of 1.5%.”
Ask for details →Yomeishu Seizo Co., Ltd. (ticker: 2540) is a company listed on JPX in the Consumer Defensive sector (Beverages - Wineries & Distilleries). It has approximately 314 employees. Market cap is $55.8B.
The current price is 4,030 with a P/E ratio of 82.11x and P/B of 1.21x.
ROE is 1.47% and operating margin is 1.28%. Annual revenue is $10.0B.